Studi relawan sehat di Greenville, SC
16 studi di lokasi sekitar Greenville menerima relawan sehat — orang tanpa kondisi yang sedang diteliti. Banyak studi membayar peserta atas waktu dan perjalanan mereka; jumlah pembayaran ditentukan oleh masing-masing studi, jadi tanyakan kepada tim studi.
Teks studi resmi (Bahasa Inggris)
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Menerima pesertaSukarelawan sehat diterima
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Cancer Institute - Eastside, Greenville
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Menerima pesertaFase 1Sukarelawan sehat diterima
- Tribe Clinical Research, LLC-Pediatrics ( Site 1008), Greenville
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Prisma Health Greenville Memorial Hospital, Greenville
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Menerima pesertaSukarelawan sehat diterima
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Cancer Institute - Eastside, Greenville
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Greenville Memorial Hospital, Greenville
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
Menerima pesertaSukarelawan sehat diterima
- Challenges, Inc/Prisma Health, Greenville
Comparison of Two Different Sperm Processing Methods and Their Effects on Sperm DNA Fragmentation and Embryo Development
Menerima pesertaSukarelawan sehat diterima
- Prisma Health-Upstate Fertility Center of the Caroliinas, Greenville
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Menerima pesertaFase 3Sukarelawan sehat diterima
- Prisma Health Maternal Fetal Medicine, Greenville
- Prisma Health OBGYN Center, Greenville
A Study of BLB-201 RSV Vaccine in Infants and Children
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- Tribe Clinical Research, LLC Parkside Pediatrics Verdae, Greenville
- Tribe Clinical Research, LLC Parkside Pediatrics, Greenville
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
Menerima pesertaSukarelawan sehat diterima
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Greenville Memorial Hospital, Greenville
- dan 1 lainnya
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
Menerima pesertaSukarelawan sehat diterima
- Phoenix Center, Greenville
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Menerima pesertaFase 1/2Sukarelawan sehat diterima
- Local Institution - 0027, Greenville
Robotic Versus Open Ventral Hernia Repair
Menerima pesertaSukarelawan sehat diterima
- Prisma Health Greenville Memorial Hospital, Greenville
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Menerima pesertaFase 3Sukarelawan sehat diterima
- GSK Investigational Site, Greenville
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Menerima pesertaFase 3Sukarelawan sehat diterima
- Saint Francis Hospital, Greenville
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- dan 2 lainnya
Prevent Cancer- Greenville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Prisma Health-Upstate, Greenville
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.